Ars Technica on Nostr: Novo Nordisk sells hit weight-loss drug in China—at fraction of US price As US ...
Novo Nordisk sells hit weight-loss drug in China—at fraction of US price
As US struggles to afford GLP-1 drugs, the rest of the world sees much lower prices.
https://arstechnica.com/health/2024/11/novo-nordisk-sells-hit-weight-loss-drug-in-china-at-fraction-of-us-price/?utm_brand=arstechnica&utm_social-type=owned&utm_source=mastodon&utm_medium=social
As US struggles to afford GLP-1 drugs, the rest of the world sees much lower prices.
https://arstechnica.com/health/2024/11/novo-nordisk-sells-hit-weight-loss-drug-in-china-at-fraction-of-us-price/?utm_brand=arstechnica&utm_social-type=owned&utm_source=mastodon&utm_medium=social